Total Clarity Wealth Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,351
Closed -$5K 1039
2022
Q2
$5K Buy
+1,351
New +$6.39K ﹤0.01% 831
2022
Q1
Sell
-1,249
Closed -$11K 983
2021
Q4
$11K Buy
1,249
+108
+9% +$943 0.01% 687
2021
Q3
$10K Buy
+1,141
New +$9.81K ﹤0.01% 689
2021
Q2
Sell
-1,141
Closed -$6K 806
2021
Q1
$6K Buy
+1,141
New +$5.64K ﹤0.01% 673

Other funds holding APEN

Total Clarity Wealth Management's APEN Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 1,351 shares — an estimated $5K sold.

Total Clarity Wealth Management first reported a position in APEN in Q1 2021 and held it in 4 quarters. The position peaked at $11K in Q4 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 1,351 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $5K.
  • Total Clarity Wealth Management first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's Apollo Endosurgery, Inc. position peaked at $11K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.